메뉴 건너뛰기




Volumn 41, Issue 3, 2013, Pages 213-217

In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci

Author keywords

Agar dilution; BSAC; Etest

Indexed keywords

DAPTOMYCIN; LINEZOLID; PENICILLIN G; TEICOPLANIN; TELAVANCIN; TIGECYCLINE; VANCOMYCIN;

EID: 84872928755     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.10.016     Document Type: Article
Times cited : (11)

References (15)
  • 1
    • 35948934631 scopus 로고    scopus 로고
    • Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model
    • DOI 10.1128/AAC.01470-06
    • I. Odenholt, E. Lowdin, and O. Cars Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model Antimicrob Agents Chemother 51 2007 3311 3316 (Pubitemid 350067545)
    • (2007) Antimicrobial Agents and Chemotherapy , vol.51 , Issue.9 , pp. 3311-3316
    • Odenholt, I.1    Lowdin, E.2    Cars, O.3
  • 2
    • 34447278781 scopus 로고    scopus 로고
    • Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus Bacteremia
    • DOI 10.1128/AAC.00939-06
    • P.A. Moise-Broder, G. Sakoulas, A. Forrest, and J.J. Schentag Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia Antimicrob Agents Chemother 51 2007 2582 2586 (Pubitemid 47047340)
    • (2007) Antimicrobial Agents and Chemotherapy , vol.51 , Issue.7 , pp. 2582-2586
    • Moise, P.A.1    Sakoulas, G.2    Forrest, A.3    Schentag, J.J.4
  • 3
    • 34247282090 scopus 로고    scopus 로고
    • The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus
    • DOI 10.1086/513203
    • F.C. Tenover, and R.C. Moellering Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus Clin Infect Dis 44 2007 1208 1215 (Pubitemid 46651246)
    • (2007) Clinical Infectious Diseases , vol.44 , Issue.9 , pp. 1208-1215
    • Tenover, F.C.1    Moellering Jr., R.C.2
  • 4
    • 2942558870 scopus 로고    scopus 로고
    • Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • DOI 10.1128/JCM.42.6.2398-2402.2004
    • G. Sakoulas, P.A. Moise-Broder, J. Schentag, A. Forrest, R.C. Moellering Jr., and G.M. Eliopoulos Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J Clin Microbiol 42 2004 2398 2402 (Pubitemid 38747480)
    • (2004) Journal of Clinical Microbiology , vol.42 , Issue.6 , pp. 2398-2402
    • Sakoulas, G.1    Moise-Broder, P.A.2    Schentag, J.3    Forrest, A.4    Moellering Jr., R.C.5    Eliopoulos, G.M.6
  • 5
    • 50949085411 scopus 로고    scopus 로고
    • Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
    • T.P. Lodise, J. Graves, A. Evans, E. Graffunder, M. Helmecke, and B.M. Lomaestro Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin Antimicrob Agents Chemother 52 2008 3315 3320
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3315-3320
    • Lodise, T.P.1    Graves, J.2    Evans, A.3    Graffunder, E.4    Helmecke, M.5    Lomaestro, B.M.6
  • 6
    • 77953703747 scopus 로고    scopus 로고
    • Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin
    • Y.K. Yoon, J.Y. Kim, D.W. Park, J.W. Sohn, and M.J. Kim Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin J Antimicrob Chemother 65 2010 1015 1018
    • (2010) J Antimicrob Chemother , vol.65 , pp. 1015-1018
    • Yoon, Y.K.1    Kim, J.Y.2    Park, D.W.3    Sohn, J.W.4    Kim, M.J.5
  • 8
    • 84872904186 scopus 로고    scopus 로고
    • BSAC Resistance Surveillance Project. [accessed 21.12.11]
    • British Society for Antimicrobial Chemotherapy. BSAC Resistance Surveillance Project. http://www.bsacsurv.org [accessed 21.12.11].
    • British Society for Antimicrobial Chemotherapy
  • 9
    • 20444384347 scopus 로고    scopus 로고
    • Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact
    • DOI 10.1086/430352
    • J.A. Silverman, L.I. Mortin, A.D. Vanpraagh, T. Li, and J. Alder Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact J Infect Dis 191 2005 2149 2152 (Pubitemid 40800587)
    • (2005) Journal of Infectious Diseases , vol.191 , Issue.12 , pp. 2149-2152
    • Silverman, J.A.1    Mortin, L.I.2    VanPraagh, A.D.G.3    Li, T.4    Alder, J.5
  • 12
    • 77952562278 scopus 로고    scopus 로고
    • Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia
    • S.S. Hegde, R. Skinner, S.R. Lewis, K.M. Krause, J. Blais, and B.M. Benton Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia J Antimicrob Chemother 65 2010 725 728
    • (2010) J Antimicrob Chemother , vol.65 , pp. 725-728
    • Hegde, S.S.1    Skinner, R.2    Lewis, S.R.3    Krause, K.M.4    Blais, J.5    Benton, B.M.6
  • 13
    • 33747173384 scopus 로고    scopus 로고
    • Comparison of dalbavancin MIC values determined by etest (AB BIODISK) and reference dilution methods using gram-positive organisms
    • DOI 10.1128/JCM.00640-06
    • T.R. Fritsche, R.P. Rennie, B.P. Goldstein, and R.N. Jones Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using Gram-positive organisms J Clin Microbiol 44 2006 2988 2990 (Pubitemid 44228601)
    • (2006) Journal of Clinical Microbiology , vol.44 , Issue.8 , pp. 2988-2990
    • Fritsche, T.R.1    Rennie, R.P.2    Goldstein, B.P.3    Jones, R.N.4
  • 14
    • 67649984927 scopus 로고    scopus 로고
    • Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus
    • H.S. Sader, P.R. Rhomberg, and R.N. Jones Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 53 2009 3162 3165
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 3162-3165
    • Sader, H.S.1    Rhomberg, P.R.2    Jones, R.N.3
  • 15
    • 78650060592 scopus 로고    scopus 로고
    • For methicillin-resistant coagulase-negative Staphylococcus isolates: Evaluation of the broth microdilution and Etest methods
    • R.M. Paiva, A.B. Mombach Pinheiro Machado, A.P. Zavascki, A.L. Barth, and Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and Etest methods J Clin Microbiol 48 2010 4652 4654
    • (2010) J Clin Microbiol , vol.48 , pp. 4652-4654
    • Paiva, R.M.1    Mombach Pinheiro MacHado, A.B.2    Zavascki, A.P.3    Barth, A.L.4    Mic, V.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.